Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 11-2024 | 11-2023 | 11-2022 | 11-2021 | |
| Sales | 83,980 | 54,549 | 76,987 | 38,627 | 29,750 |
| Gross Profit | 83,980 | 54,549 | 76,987 | 38,627 | 29,750 |
| Operating Expenses | 369,646 | 267,576 | 232,050 | 222,494 | 147,636 |
| Operating Income | -285,666 | -213,027 | -155,063 | -183,867 | -117,886 |
| Other Income | 21,969 | 19,728 | 11,115 | 3,507 | 823 |
| Pre-tax Income | -263,697 | -193,299 | -143,948 | -180,360 | -117,063 |
| Income Tax | 760 | 270 | 0 | N/A | 131 |
| Net Income Continuous | -264,457 | -193,569 | -143,948 | -180,360 | -117,194 |
| Net Income | $-264,457 | $-193,569 | $-143,948 | $-180,360 | $-117,194 |
| EPS Basic Total Ops | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| EPS Basic Continuous Ops | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| EPS Diluted Total Ops | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| EPS Diluted Continuous Ops | -3.05 | -2.88 | -2.65 | -3.71 | -2.73 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.88 | -2.65 | -3.71 | -2.73 |
| EBITDA(a) | $-277,132 | $-207,887 | $-146,830 | $-172,633 | $-110,098 |